{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "COCRYSTAL PHARMA NEW O.N.", "longName": "Cocrystal Pharma, Inc.", "messageBoardId": "finmb_49062639", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -1.6129017, "regularMarketPrice": 2.44, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.5690264, "fiftyTwoWeekLow": 0.12, "fiftyTwoWeekHigh": 5.6616, "earningsTimestamp": 1680091203, "earningsTimestampStart": 1683894600, "earningsTimestampEnd": 1684153800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -4.83, "sharesOutstanding": 10173800, "bookValue": 4.859, "fiftyDayAverage": 1.9771, "fiftyDayAverageChange": 0.46290004, "fiftyDayAverageChangePercent": 0.23413081, "twoHundredDayAverage": 2.6728215, "twoHundredDayAverageChange": -0.23282146, "twoHundredDayAverageChangePercent": -0.087107, "marketCap": 24824072, "priceToBook": 0.5021609, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": -0.03999996, "regularMarketTime": 1683871295, "regularMarketDayHigh": 2.44, "regularMarketDayRange": "2.44 - 2.44", "regularMarketDayLow": 2.44, "regularMarketVolume": 56, "regularMarketPreviousClose": 2.48, "bid": 2.44, "ask": 2.46, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 2.44, "averageDailyVolume3Month": 15, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 2.3200002, "fiftyTwoWeekLowChangePercent": 19.333336, "fiftyTwoWeekRange": "0.12 - 5.6616", "fiftyTwoWeekHighChange": -3.2216, "firstTradeDateMilliseconds": 1584082800000, "symbol": "8CC.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "19805 North Creek Parkway", "city": "Bothell", "state": "WA", "zip": "98011", "country": "United States", "phone": "305 425 1780", "website": "https://www.cocrystalpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Dr. Roger D. Kornberg Ph.D.", "age": 75, "title": "Co-Founder, Chairman, Chief Scientist & Chairman of Scientific Advisory Board", "yearBorn": 1947, "fiscalYear": 2022, "totalPay": {"raw": 125000, "fmt": "125k", "longFmt": "125,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Sam  Lee Ph.D.", "age": 62, "title": "Co-Founder, Interim Co-CEO & Pres", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": {"raw": 521384, "fmt": "521.38k", "longFmt": "521,384"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. James J. Martin CPA, CPA, M.B.A., MBA", "age": 55, "title": "Interim Co-CEO, CFO & Corp. Sec.", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 521384, "fmt": "521.38k", "longFmt": "521,384"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}